Vident Advisory LLC Has $622,000 Stock Position in Option Care Health, Inc. (NASDAQ:OPCH)

Vident Advisory LLC grew its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 132.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 26,789 shares of the company's stock after purchasing an additional 15,262 shares during the quarter. Vident Advisory LLC's holdings in Option Care Health were worth $622,000 as of its most recent SEC filing.

Other institutional investors also recently made changes to their positions in the company. Murphy & Mullick Capital Management Corp acquired a new stake in Option Care Health in the fourth quarter worth $26,000. UMB Bank n.a. increased its holdings in shares of Option Care Health by 41.7% in the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock worth $27,000 after acquiring an additional 346 shares during the period. Signaturefd LLC grew its holdings in Option Care Health by 487.9% in the 4th quarter. Signaturefd LLC now owns 1,211 shares of the company's stock worth $28,000 after buying an additional 1,005 shares in the last quarter. Quadrant Capital Group LLC increased its position in Option Care Health by 172.8% in the 4th quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company's stock valued at $40,000 after acquiring an additional 1,099 shares during the period. Finally, Johnson Financial Group Inc. bought a new stake in Option Care Health during the 4th quarter valued at $47,000. 98.05% of the stock is owned by institutional investors.

Option Care Health Price Performance

Shares of NASDAQ OPCH traded down $0.38 during mid-day trading on Wednesday, reaching $31.74. The company had a trading volume of 881,761 shares, compared to its average volume of 1,854,898. Option Care Health, Inc. has a 1-year low of $21.39 and a 1-year high of $35.53. The stock has a market cap of $5.20 billion, a PE ratio of 26.67, a P/E/G ratio of 2.30 and a beta of 0.76. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The company has a 50-day moving average price of $32.89 and a two-hundred day moving average price of $29.47.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its earnings results on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, topping the consensus estimate of $0.36 by $0.04. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. The company had revenue of $1.33 billion during the quarter, compared to analysts' expectations of $1.26 billion. During the same period last year, the company posted $0.26 earnings per share. The business's revenue for the quarter was up 16.3% on a year-over-year basis. On average, equities analysts anticipate that Option Care Health, Inc. will post 1.22 earnings per share for the current year.

Insider Activity

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the company's stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the transaction, the insider now owns 44,974 shares in the company, valued at approximately $1,495,835.24. This represents a 40.80% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 0.64% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several research firms recently weighed in on OPCH. UBS Group raised shares of Option Care Health from a "neutral" rating to a "buy" rating and upped their price objective for the stock from $38.00 to $40.00 in a report on Wednesday, April 30th. Barrington Research reiterated an "outperform" rating and issued a $38.00 price objective on shares of Option Care Health in a report on Wednesday, April 30th. JMP Securities reissued a "market outperform" rating and set a $36.00 target price on shares of Option Care Health in a report on Tuesday, April 22nd. Finally, JPMorgan Chase & Co. lifted their price target on Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a research report on Thursday, March 6th. One analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company. According to MarketBeat, Option Care Health presently has a consensus rating of "Moderate Buy" and a consensus price target of $35.50.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.